Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Any time we try a healthy new way of eating, it's easy for doubt to creep in. Is it really working? Is it worth it? Does it even matter if I give up? "That's why a continuous glucose monitor, or CGM, ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the next ...

CGM expects to return to the growth path in 2025, with organic revenue growth (adjusted for acquisitions and currency effects) in the low to mid-single digit percentage range year-on-year. Adjusted ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, AscensiaPatient ...

The advent of continuous glucose monitoring (CGM) in association with an implanted reservoir/pump administering insulin has reduced morbidities associated with diabetes. Open loop systems refer to the ...

All sections of this page are updated every week by Friday. This report includes data provided by provinces and territories on a weekly basis and are published the following week. As a result, case ...

CMA CGM SA, the world’s third-largest container line, is preparing for a one-two punch of higher tariffs and a new US maritime policy that could upend both global trade and the shipping industry. The ...

CMA CGM, controlled by the family of Chairman and CEO Rodolphe Saade, is the world's third-largest container shipping line. It has a large U.S. presence, operating several port terminals while ...